Clinical relevance of T follicular helper cells in systemic lupus erythematosus

References

• Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–2121.
   PubMed Web of Science ®Google Scholar
• Tanaka Y. State-of-the-art treatment of systemic lupus erythematosus. Int J Rheum Dis. 2020;23:465–471.
   PubMed Web of Science ®Google Scholar
• van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2014;73:958.
   PubMed Web of Science ®Google Scholar
• Deane KD, El-Gabalawy H. Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nat Rev Rheumatol. 2014;10:212–228.
   PubMed Web of Science ®Google Scholar
• Nakayamada S, Takahashi H, Kanno Y, et al. Helper T cell diversity and plasticity. Curr Opin Immunol. 2012;24:297.
   PubMed Web of Science ®Google Scholar
• Nakayamada S, Kanno Y, Takahashi H, et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity. 2011;35:919.
   PubMed Web of Science ®Google Scholar
• Lu KT, Kanno Y, Cannons JL, et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity. 2011;35:622.
   PubMed Web of Science ®Google Scholar
• Miller JF, Mitchell GF. Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med. 1968;128:801.
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Miller JF. Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med. 1968;128:821.
   PubMed Web of Science ®Google Scholar
• Nossal GJ, Cunningham A, Mitchell GF, et al. Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med. 1968;128:839.
   PubMed Web of Science ®Google Scholar
• Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol. 2015;15:185.
   PubMed Web of Science ®Google Scholar
• Howard M, Farrar J, Hilfiker M, et al. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J Exp Med. 1982;155:914.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348.
   PubMed Web of Science ®Google Scholar
• Liu YJ, Joshua DE, Williams GT, et al. Mechanism of antigen-driven selection in germinal centres. Nature. 1989;342:929.
   PubMed Web of Science ®Google Scholar
• Foy TM, Laman JD, Ledbetter JA, et al. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med. 1994;180:157.
   PubMed Web of Science ®Google Scholar
• Kopf M, Le Gros G, Coyle AJ, et al. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev. 1995;148:45.
   PubMed Web of Science ®Google Scholar
• Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000;192:1545.
   PubMed Web of Science ®Google Scholar
• Schaerli P, Willimann K, Lang AB, et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med. 2000;192:1553.
   PubMed Web of Science ®Google Scholar
• Ozaki K, Kikly K, Michalovich D, et al. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA. 2000;97:11439.
   PubMed Web of Science ®Google Scholar
• Johnston RJ, Poholek AC, DiToro D, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009;325:1006.
   PubMed Web of Science ®Google Scholar
• Nurieva RI, Chung Y, Martinez GJ, et al. Bcl6 mediates the development of T follicular helper cells. Science. 2009;325:1001.
   PubMed Web of Science ®Google Scholar
• Yu D, Rao S, Tsai LM, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31:457.
   PubMed Web of Science ®Google Scholar
• Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014;41:529.
   PubMed Web of Science ®Google Scholar
• Schmitt N, Liu Y, Bentebibel SE, et al. The cytokine TGF-b co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat Immunol. 2014;15:856.
   PubMed Web of Science ®Google Scholar
• Nakayamada S, Poholek AC, Lu KT, et al. Type I interferon induces binding of STAT1 to Bcl6: divergent roles of STAT-family transcription factors in the TFH cell genetic program. J Immunol. 2014;192:2156.
   PubMed Web of Science ®Google Scholar
• Vahedi G, Takahashi H, Nakayamada S, et al. STATs shape the active enhancer landscape of T cell populations. Cell. 2012;151:981.
   PubMed Web of Science ®Google Scholar
• Hakim O, Sung MH, Nakayamada S, et al. Spatial congregation of STAT binding directs selective nuclear architecture during T cell functional differentiation. Genome Res. 2013;23:462.
   PubMed Web of Science ®Google Scholar
• Vinuesa CG, Cook MC, Angelucci C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature. 2005;435:452.
   PubMed Web of Science ®Google Scholar
• Linterman MA, Rigby RJ, Wong RK, et al. Follicular helper T cells are required for systemic autoimmunity. J Exp Med. 2009;206:561.
   PubMed Web of Science ®Google Scholar
• Rankin AL, Guay H, Herber D, et al. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice. J Immunol. 2012;188:1656.
   PubMed Web of Science ®Google Scholar
• Bubier JA, Bennett SM, Sproule TJ, et al. Treatment of BXSB-yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Ann N Y Acad Sci. 2007;1110:590.
   PubMed Web of Science ®Google Scholar
• Bubier JA, Sproule TJ, Foreman O, et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-yaa mice. Proc Natl Acad Sci U S A. 2009;106:1518.
   PubMed Web of Science ®Google Scholar
• Choi JY, Seth A, Kashgarian M, et al. Disruption of pathogenic cellular networks by IL-21 blockade leads to disease amelioration in murine lupus. J Immunol. 2017;198:2578.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang X, Hu L, et al. E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases. J Clin Invest. 2020;130:3717–3733.
   PubMed Web of Science ®Google Scholar
• Faliti CE, Gualtierotti R, Rottoli E, et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med. 2019;216:317–336.
   PubMed Web of Science ®Google Scholar
• Jacquemin C, Schmitt N, Contin-Bordes C, et al. OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity. 2015;42:1159–1170. Epub 2015 Jun 9.
   PubMed Web of Science ®Google Scholar
• Cortini A, Ellinghaus U, Malik TH, et al. B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis. Ann Rheum Dis. 2017;76:2095–2103. Epub 2017 Aug 17.
   PubMed Web of Science ®Google Scholar
• Jacquemin C, Augusto JF, Scherlinger M, et al. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE. JCI Insight. 2018;3:e122167.
   PubMed Web of Science ®Google Scholar
• Teruel M, Alarcón-Riquelme ME. The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun. 2016;74:161.
   PubMed Web of Science ®Google Scholar
• Su C, Johnson ME, Torres A, et al. Mapping effector genes at lupus GWAS loci using promoter Capture-C in follicular helper T cells. Nat Commun. 2020;11:3294.
   PubMed Web of Science ®Google Scholar
• Simpson N, Gatenby PA, Wilson A, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010;62:234.
   PubMed Web of Science ®Google Scholar
• Wong CK, Wong PT, Tam LS, et al. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol. 2010;30:45.
   PubMed Web of Science ®Google Scholar
• Choi JY, Ho JH, Pasoto SG, et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 2015;67:988.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao P, Ma L, et al. Increased interleukin-21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus. J Rheumatol. 2014;41:1781–1792.
   PubMed Web of Science ®Google Scholar
• He J, Tsai LM, Leong YA, et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity. 2013;39:770–781.
   PubMed Web of Science ®Google Scholar
• Xu H, Liu J, Cui X, et al. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner. Cell Immunol. 2015;295:46–51.
   PubMed Web of Science ®Google Scholar
• Szabó K, Papp G, Szántó A, et al. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary sjögren’s syndrome and systemic lupus erythematosus. Clin Exp Immunol. 2016;183:76–89.
   PubMed Web of Science ®Google Scholar
• Terrier B, Costedoat-Chalumeau N, Garrido M, et al. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus. J Rheumatol. 2012;39:1819–1828.
   PubMed Web of Science ®Google Scholar
• Feng X, Wang D, Chen J, et al. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS One. 2012;7:e51982.
   PubMed Web of Science ®Google Scholar
• Yang X, Yang J, Chu Y, et al. T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus. PLoS One. 2014;9:e88441.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lindwall E, Gauthier C, et al. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. Lupus. 2015;24:909–917.
   PubMed Web of Science ®Google Scholar
• Huang X, Wu H, Qiu H, et al. The expression of Bcl-6 in circulating follicular helper-like T cells positively correlates with the disease activity in systemic lupus erythematosus. Clin Immunol. 2016;173:161–170.
   PubMed Web of Science ®Google Scholar
• Liarski VM, Kaverina N, Chang A, et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med. 2014;6:230ra46.
   PubMed Web of Science ®Google Scholar
• Ma X, Nakayamada S, Kubo S, et al. Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors. Ann Rheum Dis. 2018;77:1354.
   PubMed Web of Science ®Google Scholar
• Dong X, Antao OQ, Song W, et al. Type I interferon-activated STAT4 regulation of follicular helper T cell-dependent cytokine and immunoglobulin production in lupus. Arthritis Rheumatol. 2021;73:478–489. Epub 2021 Jan 29.
   PubMed Web of Science ®Google Scholar
• Le Coz C, Joublin A, Pasquali J-L, et al. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease. PLoS One. 2013;8:e75319.
   PubMed Web of Science ®Google Scholar
• Kim CJ, Lee CG, Jung JY, et al. The transcription factor Ets1 suppresses T follicular helper type 2 cell differentiation to halt the onset of systemic lupus erythematosus. Immunity. 2018;49:1034.
   PubMed Web of Science ®Google Scholar
• Bocharnikov AV, Keegan J, Wacleche VS, et al. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight. 2019;4:e130062.
   PubMed Web of Science ®Google Scholar
• Caielli S, Veiga DT, Balasubramanian P, et al. A CD4+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate. Nat Med. 2019;25:75.
   PubMed Web of Science ®Google Scholar
• Xu B, Wang S, Zhou M, et al. The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus. Clin Immunol. 2017;183:46.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang D, Song Y, et al. Increased circulating CD4+CXCR5+FoxP3+ follicular regulatory T cells correlated with severity of systemic lupus erythematosus patients. Int Immunopharmacol. 2018;56:261.
   PubMed Web of Science ®Google Scholar
• Hao H, Nakayamada S, Yamagata K, et al. Conversion of T follicular helper cells to T follicular regulatory cells by interleukin-2 through transcriptional regulation in systemic lupus erythematosus. Arthritis Rheumatol. 2021;73:132–142.
   PubMed Web of Science ®Google Scholar
• Lee SK, Silva DG, Martin JL, et al. Interferon-γ excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity. 2012;37:880.
   PubMed Web of Science ®Google Scholar
• Arkatkar T, Du SW, Jacobs HM, et al. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J Exp Med. 2017;214:3207–3217. Epub 2017 Sep 12.
   PubMed Web of Science ®Google Scholar
• Sircy LM, Harrison-Chau M, Novis CL, et al. Protein immunization induces memory CD4 + T cells that lack Th lineage commitment. J Immunol. 2020;207:1388-1400.
   Google Scholar
• Alterauge D, Bagnoli JW, Dahlström F, et al. Continued Bcl6 expression prevents the transdifferentiation of established Tfh cells into Th1 cells during acute viral infection. Cell Rep. 2020;33:108232.
   PubMed Web of Science ®Google Scholar
• Weinstein JS, Laidlaw BJ, Lu Y, et al. STAT4 and T-bet control follicular helper T cell development in viral infections. J Exp Med. 2018;215:337.
   PubMed Web of Science ®Google Scholar
• Zhang H, Hu Q, Zhang M, et al. Bach2 deficiency leads to spontaneous expansion of IL-4-producing T follicular helper cells and autoimmunity. Front Immunol. 2019;10:2050.
   PubMed Web of Science ®Google Scholar
• Henault J, Riggs JM, Karnell JL, et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol. 2016;17:196.
   PubMed Web of Science ®Google Scholar
• Nalbandian A, Crispín JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009;157:209.
   PubMed Web of Science ®Google Scholar
• Le Coz C, Joublin A, Pasquali JL, et al. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease. PLoS One. 2013;8:e75319.
   PubMed Web of Science ®Google Scholar
• Wen Z, Xu L, Xu W, et al. Retinoic acid receptor-related orphan nuclear receptor γt licenses the differentiation and function of a unique subset of follicular helper T cells in response to immunogenic self-DNA in systemic lupus erythematosus. Arthritis Rheumatol. 2021;73:1489.
   PubMed Web of Science ®Google Scholar
• Craft JE. Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol. 2012;8:337.
   PubMed Web of Science ®Google Scholar
• Morita R, Schmitt N, Bentebibel SE, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34:108.
   PubMed Web of Science ®Google Scholar
• Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110.
   PubMed Web of Science ®Google Scholar
• Facciotti F, Larghi P, Bosotti R, et al. Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6 + B helper T cells in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2020;117:7305–7316. Epub 2020 Mar 17.
   PubMed Web of Science ®Google Scholar
• Linterman MA, Pierson W, Lee SK, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17:975–982.
   PubMed Web of Science ®Google Scholar
• Wollenberg I, Agua-Doce A, Hernández A, et al. Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J Immunol. 2011;187:4553–4560.
   PubMed Web of Science ®Google Scholar
• Chung Y, Tanaka S, Chu F, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011;17:983–988.
   PubMed Web of Science ®Google Scholar
• Deng J, Wei Y, Fonseca VR, et al. T follicular helper cells and T follicular regulatory cells in rheumatic diseases. Nat Rev Rheumatol. 2019;15:475.
   PubMed Web of Science ®Google Scholar
• Hao H, Nakayamada S, Tanaka Y. Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases. Inflamm Regen. 2021;41:14.
   PubMed Web of Science ®Google Scholar
• He J, Zhang X, Wei Y, et al. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. Nat Med. 2016;22:991.
   PubMed Web of Science ®Google Scholar
• von Spee-Mayer C, Siegert E, Abdirama D, et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2016;75:1407.
   PubMed Web of Science ®Google Scholar
• He J, Zhang R, Shao M, et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2020;79:141.
   PubMed Web of Science ®Google Scholar
• Kubo S, Nakayamada S, Yoshikawa M, et al. Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients. Arthritis Rheumatol. 2017;69:2029.
   PubMed Web of Science ®Google Scholar
• Iwata S, Saito K, Tokunaga M, et al. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab. J Rheumatol. 2011;38:633.
   PubMed Web of Science ®Google Scholar
• Nakayamada S, Iwata S, Tanaka Y. Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus. Int J Rheum Dis. 2015;18:208.
   PubMed Web of Science ®Google Scholar
• Vallerskog T, Gunnarsson I, Widhe M, et al. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol. 2007;122:62.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Souliotis VL, Fragiadaki KG, et al. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol. 2007;123:66.
   PubMed Web of Science ®Google Scholar
• Stohl W, Hiepe F, Latinis KM, et al. Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum. 2012;64:2328.
   PubMed Web of Science ®Google Scholar
• Regola F, Piantoni S, Lowin T, et al. Association between changes in BLyS levels and the composition of B and T cell compartments in patients with refractory systemic lupus erythematosus treated with belimumabs. Front Pharmacol. 2019;10:433.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Kubo S, Iwata S, et al. B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus. Clin Immunol. 2018;186:21–25.
   PubMed Web of Science ®Google Scholar
• Banchereau R, Hong S, Cantarel B, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165:551–565.
   PubMed Web of Science ®Google Scholar
• Hagberg N, Joelsson M, Leonard D, et al. The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE. Ann Rheum Dis. 2018;77:1070.
   PubMed Web of Science ®Google Scholar
• Hasni SA, Gupta S, Davis M, et al. Association between changes in BLyS levels and the composition of B and T cell compartments in patiephase 1 double-blind randomized safety trial of the janus kinase inhibitor tofacitinib in systemic lupus erythematosus. Nat Commun. 2021;12:3391.
   PubMed Web of Science ®Google Scholar
• Ma X, Nakayamada S, Wang J. Multi-source pathways of T follicular helper cell differentiation. Front Immunol. 2021;12:621105.
   PubMed Web of Science ®Google Scholar